Skip to main content
. 2014 Feb 28;3(3):623–631. doi: 10.1002/cam4.221

Figure 1.

Figure 1

Probability of event-free survival (EFS) and overall survival (OS) in pediatric B-cell precursor acute lymphoblastic leukemia patients with TCF3-PBX1 fusion treated according to the JACLS ALL02 (n = 82, A and B) and CCLSG ALL2004 protocol (n = 30, C and D). (A and C) EFS, (B and D) OS. JACLS, Japan Association Childhood Leukemia Study; CCLSG, Children's Cancer and Leukemia Study Group.